tPA also initiates the degradation of amyloid-β (Aβ), resulting in decreasing level of Aβ derived from amyloid precursor protein (APP), which may delay pathogenic progression of Alzheimer's disease (AD). The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.